Skip to main content

DESARROLLO DE NUEVAS TECNOLOGIAS PARA LA EDICION PRECISA Y EFICIENTE DEL GENOMA HUMANO

SAF2017-88784-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Find and cut-and-transfer (FiCAT) mammalian genome engineering

  • Pallarès-Masmitjà, Maria
  • Ivančić, Dimitrije
  • Mir-Pedrol, Júlia
  • Jaraba-Wallace, Jessica
  • Tagliani, Tommaso
  • Oliva Miguel, Baldomero
  • Rahmeh, Amal
  • Sánchez-Mejías, Avencia
  • Güell Cargol, Marc, 1982-
While multiple technologies for small allele genome editing exist, robust technologies for targeted integration of large DNA fragments in mammalian genomes are still missing. Here we develop a gene delivery tool (FiCAT) combining the precision of a CRISPR-Cas9 (find module), and the payload transfer efficiency of an engineered piggyBac transposase (cut-and-transfer module). FiCAT combines the functionality of Cas9 DNA scanning and targeting DNA, with piggyBac donor DNA processing and transfer capacity. PiggyBac functional domains are engineered providing increased on-target integration while reducing off-target events. We demonstrate efficient delivery and programmable insertion of small and large payloads in cellulo (human (Hek293T, K-562) and mouse (C2C12)) and in vivo in mouse liver. Finally, we evolve more efficient versions of FiCAT by generating a targeted diversity of 394,000 variants and undergoing 4 rounds of evolution. In this work, we develop a precise and efficient targeted insertion of multi kilobase DNA fragments in mammalian genomes., The authors received funding from UPGRADE (European Union Horizon 2020, grant agreement No 825825); Fundació La Caixa: Caixa Impulse 2018 (grant agreement CI 1800036), Caixa Impulse Consolidate 2019 (grant agreement cF91-00010) and Programa Captació de Talent; Fundación Ramón Areces (“Advanced gene editing technologies to restore LAMA2 on merosin-deficient congenital muscular dystrophy type 1A”); Ministerio de Economia, Industria y Competitividad de España (Plan Estatal 2013-2016 (Grant agreement SAF2017-88784-R, Ramón y Cajal program (Grant agreement RYC-2015-17734)). All grants were received by M.G.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Find and cut-and-transfer (FiCAT) mammalian genome engineering

  • Pallarès-Masmitjà, Maria
  • Ivančić, Dimitrije
  • Mir-Pedrol, Júlia
  • Jaraba-Wallace, Jessica
  • Tagliani, Tommaso
  • Oliva Miguel, Baldomero
  • Rahmeh, Amal
  • Sánchez-Mejías, Avencia
  • Güell Cargol, Marc, 1982-
While multiple technologies for small allele genome editing exist, robust technologies for targeted integration of large DNA fragments in mammalian genomes are still missing. Here we develop a gene delivery tool (FiCAT) combining the precision of a CRISPR-Cas9 (find module), and the payload transfer efficiency of an engineered piggyBac transposase (cut-and-transfer module). FiCAT combines the functionality of Cas9 DNA scanning and targeting DNA, with piggyBac donor DNA processing and transfer capacity. PiggyBac functional domains are engineered providing increased on-target integration while reducing off-target events. We demonstrate efficient delivery and programmable insertion of small and large payloads in cellulo (human (Hek293T, K-562) and mouse (C2C12)) and in vivo in mouse liver. Finally, we evolve more efficient versions of FiCAT by generating a targeted diversity of 394,000 variants and undergoing 4 rounds of evolution. In this work, we develop a precise and efficient targeted insertion of multi kilobase DNA fragments in mammalian genomes., The authors received funding from UPGRADE (European Union Horizon 2020, grant agreement No 825825); Fundació La Caixa: Caixa Impulse 2018 (grant agreement CI 1800036), Caixa Impulse Consolidate 2019 (grant agreement cF91-00010) and Programa Captació de Talent; Fundación Ramón Areces (“Advanced gene editing technologies to restore LAMA2 on merosin-deficient congenital muscular dystrophy type 1A”); Ministerio de Economia, Industria y Competitividad de España (Plan Estatal 2013-2016 (Grant agreement SAF2017-88784-R, Ramón y Cajal program (Grant agreement RYC-2015-17734)). All grants were received by M.G.